Finding a cure: Alzheimer’s patient helps test new drug
We are the only location in NC offering this break through study: Why is this drug being tested? It may be acting upstream of all the defects in Alzheimer’s brains going after the possible cause [...]
SCRS Global Summit
New Hope attended the Global Site Solutions Summit to gain knowledge and collaborate with other industry professionals and experts in the field of clinical research. Where Sites, Sponsors & CROs Partner for Success The Global [...]
3 Distinct Subtypes of Alzheimer’s
A new University of California, Los Angeles study finds that Alzheimer’s disease, long thought to be a single disease, really consists of three distinct subtypes. Experts believe the finding could lead to more highly targeted [...]
The Hope for Mental Illness
It has been 10 years since Dr. Tom Insel, director of the National Institute of Mental Health (NIMH) first started attending events held by NAMI. In that time, research on mental illness has continued to [...]
Study of Twins Provides Alzheimer’s Blood Protein Clue
A protein has been discovered in the blood of people who go on to develop mild cognitive impairment several years later. Dr. Steven Kiddle of King’s College London, UK, and colleagues explain there currently are [...]
Repairing the brain: Two genes unlock potential for treatment of schizophrenia
Research led by scientists from Duke-NUS Graduate Medical School Singapore (Duke-NUS) has linked the abnormal behaviour of two genes (BDNF and DTNBP1) to the underlying cause of schizophrenia. These findings have provided a new target [...]
NHCR Passes FDA Audit
New Hope Clinical Research, an independent clinical research site, today announced that the U. S. Food and Drug Administration (FDA) concluded its Routine inspection of the New Hope Clinical Trials facility. The inspection took place [...]